Long-Acting Glucagon-Like Peptide-1 Receptor Agonist-Induced Rheumatoid Arthritis in a Patient with Type 2 Diabetes Mellitus

Case Presentation: We report a case of a male patient with rheumatoid arthritis (RA) diagnosed during treatment with a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist (once-weekly dulaglutide injection). At 3 months after dulaglutide initiation, he began experiencing left shoulder pain...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Koji Kikkawa, Hiroto Hoshi, Atsushi Isoda, Kazuya Okada, Junichi Okada, Takuya Watanabe, Eijiro Yamada, Kihachi Ohshima, Shuichi Okada
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Knowledge E 2021-09-01
coleção:	Dubai Diabetes and Endocrinology Journal
Assuntos:	adverse drug reactions rheumatoid arthritis glucagon-like peptide-1 receptor agonist
Acesso em linha:	https://www.karger.com/Article/FullText/519008
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!